Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome

Recruiting

Phase 2

Pain Patch vs. InjectionsPain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome

Sponsor:

Injury Care Medical Center

Code:

NCT01544283

Conditions

Shoulder Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Synera® (lidocaine 70 mg and tetracaine 70 mg) topical patch

Triamcinolone Acetonide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-17. This information was provided to ClinicalTrials.gov by Injury Care Medical Center on 2012-03-06.